Want to see IN:JHS full AI Analyst Report?
JHS Stock Chart & Stats
₹7.41
-₹0.09(-1.20%)
At close: 4:00 PM EDT
₹7.41
-₹0.09(-1.20%)
Day’s Range― - ―
52-Week Range₹6.15 - ₹13.83
Previous CloseN/A
Volume57.65K
Average Volume (3M)16.78K
Market Cap
₹742.07M
Enterprise Value₹858.31
Total Cash (Recent Filing)₹191.00M
Total Debt (Recent Filing)₹148.51M
Price to Earnings (P/E)―
Beta1.16
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding87,405,770
10 Day Avg. Volume16,348
30 Day Avg. Volume16,781
Financial Highlights & Ratios
PEG Ratio0.33
Price to Book (P/B)0.33
Price to Sales (P/S)0.56
P/FCF Ratio-3.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue RecoveryThe FY2026 rebound indicates renewed demand for JHS’s manufactured consumer products. Sustained volume recovery could improve facility utilization and operating leverage, although consistency across future periods remains important.
Low Financial LeverageLow leverage reduces solvency risk and interest-related pressure, giving JHS more financial flexibility while it works to restore profitability. Stable assets and equity also provide a stronger foundation than a highly debt-funded balance sheet.
Improving Operating ProfitabilityA return to positive EBITDA suggests operating performance is responding to the revenue recovery. If maintained, this improvement could support better absorption of manufacturing costs and create a path toward eventual net profitability.
Bears Say
Persistent Net LossesContinuing losses show that revenue recovery has not yet translated into sustainable shareholder returns. Negative operating earnings limit internal funding capacity and leave the business exposed if pricing, costs, or production volumes deteriorate.
Weak Cash GenerationRecurring operating and free-cash-flow deficits indicate that reported improvement is not yet converting into cash. Persistent cash burn can constrain investment, increase reliance on working-capital movements, and eventually require external funding.
Revenue VolatilityThe uneven revenue pattern suggests demand, customer orders, or production utilization may not yet be dependable. Volatility makes capacity planning harder and can prevent fixed manufacturing costs from being covered consistently.
JHS Svendgaard Laboratories Limited News
JHS FAQ
What was JHS Svendgaard Laboratories Limited’s price range in the past 12 months?
JHS Svendgaard Laboratories Limited lowest stock price was ₹6.15 and its highest was ₹13.83 in the past 12 months.
What is JHS Svendgaard Laboratories Limited’s market cap?
JHS Svendgaard Laboratories Limited’s market cap is ₹742.07M.
When is JHS Svendgaard Laboratories Limited’s upcoming earnings report date?
JHS Svendgaard Laboratories Limited’s upcoming earnings report date is Nov 11, 2026 which is in 82 days.
How were JHS Svendgaard Laboratories Limited’s earnings last quarter?
JHS Svendgaard Laboratories Limited released its earnings results on Aug 11, 2026. The company reported ₹0.127 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is JHS Svendgaard Laboratories Limited overvalued?
According to Wall Street analysts JHS Svendgaard Laboratories Limited’s price is currently Overvalued.
Does JHS Svendgaard Laboratories Limited pay dividends?
JHS Svendgaard Laboratories Limited pays a Annually dividend of ₹3.64 which represents an annual dividend yield of N/A. See more information on JHS Svendgaard Laboratories Limited dividends here
What is JHS Svendgaard Laboratories Limited’s EPS estimate?
JHS Svendgaard Laboratories Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does JHS Svendgaard Laboratories Limited have?
JHS Svendgaard Laboratories Limited has 87,405,770 shares outstanding.
What happened to JHS Svendgaard Laboratories Limited’s price movement after its last earnings report?
JHS Svendgaard Laboratories Limited reported an EPS of ₹0.127 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 14.591%.
Which hedge fund is a major shareholder of JHS Svendgaard Laboratories Limited?
Currently, no hedge funds are holding shares in IN:JHS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
JHS Svendgaard Laboratories Limited
JHS Svendgaard Laboratories Limited, along with its associated companies, specializes in the manufacturing and sale of a diverse array of oral and dental hygiene products, catering to both adults and children throughout India. Their extensive product range includes essential oral care items such as toothbrushes, toothpastes, and mouthwashes, predominantly marketed under the Dr. Gold and Aquawhite brand names. The company also produces other personal and household goods, including hand sanitizers, laundry detergents, room fresheners, and denture care solutions. Beyond its own brands, JHS Svendgaard Laboratories provides contract manufacturing services for oral care products to other companies and operates retail outlets within various airports. The firm also engages in international trade, exporting its goods to global markets. Established in 1996, the company's base of operations is situated in New Delhi, India.
Technical Analysis
Colgate-Palmolive (India) Limited
―
Dabur India Limited
―
Emami Limited
―
Godrej Consumer Products Limited
―
Honasa Consumer Limited
―